Subscribe To
Affirm holdings (afrm) gains but lags market: what you should know
Affirm Holdings (AFRM) closed the most recent trading day at $101.16, moving +0.09% from the previous trading session....
December 23, 2021, 7:08 pm
Affirm holdings (afrm) gains but lags market: what you should know
Affirm Holdings (AFRM) closed the most recent trading day at $101.16, moving +0.09% from the previous trading session....
December 23, 2021, 7:08 pm
Affirm holdings (afrm) gains but lags market: what you should know
Affirm Holdings (AFRM) closed the most recent trading day at $101.16, moving +0.09% from the previous trading session....
December 23, 2021, 7:08 pm
Uniqure shares fall after clinical update from huntington's disease gene therapy trial
UniQure NV (NASDAQ: QURE) announced initial observations on the first four patients enrolled in the lower-dose cohort of Phase 1/2 trial of AMT-130...
December 16, 2021, 1:10 pm
Uniqure shares fall after clinical update from huntington's disease gene therapy trial
UniQure NV (NASDAQ: QURE) announced initial observations on the first four patients enrolled in the lower-dose cohort of Phase 1/2 trial of AMT-130...
December 16, 2021, 1:10 pm
Uniqure shares fall after clinical update from huntington's disease gene therapy trial
UniQure NV (NASDAQ: QURE) announced initial observations on the first four patients enrolled in the lower-dose cohort of Phase 1/2 trial of AMT-130...
December 16, 2021, 1:10 pm
Ebang seeks to diversify but faces delays
Ebang International went public in June 2020, raising $101 million in gross proceeds in a U.S. IPO. The...
December 6, 2021, 1:42 pm
Ebang seeks to diversify but faces delays
Ebang International went public in June 2020, raising $101 million in gross proceeds in a U.S. IPO. The...
December 6, 2021, 1:42 pm
Ebang seeks to diversify but faces delays
Ebang International went public in June 2020, raising $101 million in gross proceeds in a U.S. IPO. The...
December 6, 2021, 1:42 pm
Xyld: the global x s&p 500 covered call etf generating 9% forward yields
XYLD has generated 101 consecutive distributions of income since its inception in June of 2013 by utili...
November 28, 2021, 9:30 am
Xyld: the global x s&p 500 covered call etf generating 9% forward yields
XYLD has generated 101 consecutive distributions of income since its inception in June of 2013 by utili...
November 28, 2021, 9:30 am
Xyld: the global x s&p 500 covered call etf generating 9% forward yields
XYLD has generated 101 consecutive distributions of income since its inception in June of 2013 by utili...
November 28, 2021, 9:30 am
Adma biologics: turning a corner
On November 10th, ADMA reported a great quarter. Revenue grew to $20.68M, up 101.2% y/y, and the Company reached a number of milestones....
November 20, 2021, 2:01 pm
Adma biologics: turning a corner
On November 10th, ADMA reported a great quarter. Revenue grew to $20.68M, up 101.2% y/y, and the Company reached a number of milestones....
November 20, 2021, 2:01 pm
Adma biologics: turning a corner
On November 10th, ADMA reported a great quarter. Revenue grew to $20.68M, up 101.2% y/y, and the Company reached a number of milestones....
November 20, 2021, 2:01 pm
Gr silver mining files resource estimate for plomosas project, which shows 10.3 million silver-equivalent indicated ounces
GR Silver Mining Ltd told investors it has now filed its NI 43 -101 resource estimate for the Plomosas...
October 11, 2021, 7:49 am
Gr silver mining files resource estimate for plomosas project, which shows 10.3 million silver-equivalent indicated ounces
GR Silver Mining Ltd told investors it has now filed its NI 43 -101 resource estimate for the Plomosas...
October 11, 2021, 7:49 am
Gr silver mining files resource estimate for plomosas project, which shows 10.3 million silver-equivalent indicated ounces
GR Silver Mining Ltd told investors it has now filed its NI 43 -101 resource estimate for the Plomosas...
October 11, 2021, 7:49 am
Regenxbio presents positive initial data from phase ii altitude™ trial of rgx-314 for the treatment of diabetic retinopathy using suprachoroidal delivery at american society of retina specialists annu
ROCKVILLE, Md., Oct. 9, 2021 /PRNewswire/ -- Suprachoroidal delivery of RGX-314 well tolerated in 15 patients in Cohort 1 with no drug-related serious...
October 9, 2021, 11:23 am
Regenxbio presents positive initial data from phase ii altitude™ trial of rgx-314 for the treatment of diabetic retinopathy using suprachoroidal delivery at american society of retina specialists annu
ROCKVILLE, Md., Oct. 9, 2021 /PRNewswire/ -- Suprachoroidal delivery of RGX-314 well tolerated in 15 patients in Cohort 1 with no drug-related serious...
October 9, 2021, 11:23 am